*it is a serotonin-3 (5-ht3) receptor antagonist indicated in adults for (moderately to highly) emetogenic cancer chemotherapy and prevention of postoperative nausea and vomiting (ponv) for up to 24 hours following surgery. *it is also indicated in pediatric patients aged 1 month to less than 17 years for prevention of acute nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy, including highly emetogenic cancer chemotherapy.
Voir plus de détails